What are the primary clinical signs of pyrethrin/pyrethroid toxicosis in animals?

Get ready for the ACVPM Toxicology Exam with our comprehensive quiz. Enhance your knowledge with multiple-choice questions and detailed explanations. Prepare effectively for your certification exam!

Multiple Choice

What are the primary clinical signs of pyrethrin/pyrethroid toxicosis in animals?

Explanation:
Neurological signs are the main clinical feature because pyrethroid compounds alter voltage-gated sodium channels in nerve membranes, causing prolonged depolarization and repetitive firing. This leads to tremors, ataxia, restlessness or agitation, heightened sensitivity to touch, and, in more severe cases, seizures. GI signs like vomiting can occur but are not the defining problem. The course typically unfolds over hours to a couple of days, and with prompt decontamination and supportive care many animals recover within 24–72 hours; however, severe exposures can progress to fatal CNS depression or seizures within that same time frame. Cardiovascular collapse is not the primary presentation, and skin lesions are not characteristic of systemic pyrethroid toxicosis.

Neurological signs are the main clinical feature because pyrethroid compounds alter voltage-gated sodium channels in nerve membranes, causing prolonged depolarization and repetitive firing. This leads to tremors, ataxia, restlessness or agitation, heightened sensitivity to touch, and, in more severe cases, seizures. GI signs like vomiting can occur but are not the defining problem. The course typically unfolds over hours to a couple of days, and with prompt decontamination and supportive care many animals recover within 24–72 hours; however, severe exposures can progress to fatal CNS depression or seizures within that same time frame. Cardiovascular collapse is not the primary presentation, and skin lesions are not characteristic of systemic pyrethroid toxicosis.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy